2-(4-(Methoxymethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

3,3-DIMETHYL-1H-PYRROLO[2,3-B]PYRIDIN-2(3H)-ONE, 95.0%, 500mg

Toceranib Phosphate, 5g

Recipiente di reazione a flangia piatta, cilindrico, graduato, con camicia di rinvenimento e sottovuoto e valvola di drenaggio, DN 100, 4000 ml, 250 mm, 1 Pezzo

N-(4-Chlorophenyl)-2,6-difluorobenzamide, 95.0%, 1g

Propanoic acid, 2-nitro-, 1,1-dimethylethyl ester, 98%, 10g

(R)-(2-Methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazol-2-yl)methanol, 97%, 1g

10,15-Dihydro-5H-diindeno[1,2-a:1',2'-c]fluorene, 98%, 250mg

(S)-(+)-Abscisic Acid>98.0%(HPLC)100mg

N-(4-Bromophenyl)-3-oxobutanamide, 95.0%, 10g

(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-acetylphenyl)propanoic acid, 98%, 250mg

1-(Benzo[d][1,3]dioxol-5-yl)cyclobutane-1-carbonitrile, 98%, 250mg

(R)-(+)-3-Chloro-1-phenylpropanol, 97.0%, 5g